Trending News

OCC Issues Bulletins on Customer Financial Record Protections and Politicized Debanking

Homebuyers Privacy Protection Act Signed Into Law, Restricting Trigger Leads

E-Verify Update: New Guidance for Employers on EAD Revocations

Responses to DOD Survey on Alternatives to TSCA High Priority Chemicals Due September 26, 2025

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman
Posted On Monday, September 15, 2025
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
Posted On Monday, September 15, 2025
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Posted On Monday, September 15, 2025
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
Posted On Monday, September 15, 2025
Botany Scientifics Wins “Top Full Spectrum Hemp Products 2025” Award from Cannabis Business Insights Magazine
Posted On Monday, September 15, 2025
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
Posted On Monday, September 15, 2025
ROTH Further Expands its Equity Research Team with the Addition of Adam Walsh, MD and Nick Pope
Posted On Monday, September 15, 2025
Excision BioTherapeutics Announces Positive Preclinical Data Highlighting the Safety, Potency and Development Progress of the Hepatitis B EBT-107 Program at the ICE-HBV “Hepatitis B Cure Symposium”
Posted On Monday, September 15, 2025
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
Posted On Monday, September 15, 2025
Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury
Posted On Monday, September 15, 2025
ABLi Therapeutics to Present “Clinical Breakthrough Lecture” at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Posted On Monday, September 15, 2025
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
Posted On Monday, September 15, 2025
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
Posted On Monday, September 15, 2025
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases
Posted On Monday, September 15, 2025
Avalyn to Highlight AURA-IPF Phase 2 Clinical Trial Design for AP02, Inhaled Nintedanib, at the European Respiratory Society International Congress 2025
Posted On Monday, September 15, 2025
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
Posted On Monday, September 15, 2025
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
Posted On Monday, September 15, 2025
Harrow Announces Agenda and Speakers for Investor & Analyst Day
Posted On Monday, September 15, 2025
Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer
Posted On Monday, September 15, 2025
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
Posted On Monday, September 15, 2025
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
Posted On Monday, September 15, 2025
Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada
Posted On Monday, September 15, 2025
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
Posted On Monday, September 15, 2025
Performer 8 Male Enhancement “Launch” The Herbal Performance Enhancer Non Prescription ED Pills for Men 2025 over the counter by Performer 8
Posted On Sunday, September 14, 2025
TestoPrime Launch: Advanced Testosterone Booster for Men Over 50’ For Muscle Gain | Does TestoPrime Actually Work?
Posted On Sunday, September 14, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print